| Literature DB >> 36009969 |
Lina Zhao1, Xinxin Xia2, Ting Yuan1, Junying Zhu1, Zhen Shen1, Min Li1,3.
Abstract
This study analyzed genomic data of 4643 strains of carbapenemase-carrying Klebsiella pneumoniae (KPN) in China by using the Kleborate software package. The data showed rich diversity in carbapenemase-carrying KPN genomes, which contain not only 152 sequence types but also 90 capsular serotypes. In 2013, the transfer of carbapenemase to hypervirulent Klebsiella pneumoniae (HvKP) of KL1 and KL2 occurred, and since 2014, the propagation of carbapenemase into mammals, poultry, and insects has been detected. The ST11 capsular serotype had a reversal of the prevalence of KL47 and KL64 in 2016, with KL64 replacing KL47 as the dominant serotype. Colibactin is a very suitable indicator to differentiate KL1-type HvKP and classic Klebsiella pneumoniae. The most prevalent yersiniabactin of KL1 is ybt1 ICEKp10, and that of ST11 carbapenem-resistant KPN(ST11-CRKP) is ybt9 ICEKp3. The virulence genes of KL1 carbapenem-resistant hypervirulent KPN (KL1-CRHvKP), as well as ST65- and ST86-type KL2-CRHvKP, were not lost after carbapenemase was obtained.Entities:
Keywords: Klebsiella pneumoniae; antimicrobial resistance; carbapenemase; serotype; virulence
Year: 2022 PMID: 36009969 PMCID: PMC9405458 DOI: 10.3390/antibiotics11081100
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Carbapenemase type and geographical distribution of carbapenemase-carrying KPN.
Figure 2ST types (a) and carbapenemase types of KPN (b–d).
Figure 3Distribution of carbapenemase-carrying non-human, KL1, and KL2 KPN. (a) Carbapenemase-carrying non-human KPN; (b) KL1 carbapenemase-carrying KPN; (c) KL2 carbapenemase-carrying KPN.
Virulence genes of HvKP and CKP with antimicrobial sensitivity and resistance.
| Species | Aerobactin ( | Colibactin ( | Salmochelin ( | Yersiniabactin | RmpADC | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type | No. | Prevalence | Type | No. | Prevalence | Type | No. | Prevalence | Type | No. | Prevalence | Type | No. | Prevalence | |
| KL1 (270) |
| 242 | 89.6% |
| 226 | 83.7% |
| 234 | 86.6% | 239 | 88.5% | 225 | 83.3% | ||
| ESBL− a;Carb− b | - | 20 | 7.4% | - | 28 | 10.3% | - | 17 | 6.2% | 17 | 6.2% | - | 24 | 8.8% | |
| 14 | 5.1% | ||||||||||||||
| KL1 (31) |
| 28 | 90.3% |
| 30 | 96.7% |
| 27 | 87.1% | 30 | 96.7% | 25 | 80.6% | ||
| Carb+ c | - | 3 | 9.7% | - | 1 | 3.2% | - | 4 | 12.9% | - | 4 | 12.9% | |||
| KL2 (129) |
| 98 | 75.9% | - | 84 | 65.1% |
| 101 | 78.2% | - | 57 | 44.1% | 95 | 73.6% | |
| ESBL−; Carb− | - | 17 | 13.1% |
| 35 | 27.1% | - | 14 | 10.8% | 36 | 27.9% | - | 16 | 12.4% | |
|
| 9 | 6.9% |
| 8 | 6.2% |
| 9 | 6.9% | 9 | 6.9% | 9 | 6.9% | |||
| KL2 (42) | - | 21 | 50.0% | - | 36 | 85.7% | - | 26 | 61.9% | - | 16 | 38.0% | - | 26 | 61.9% |
| Carb+ |
| 11 | 26.1% |
| 5 | 11.9% |
| 13 | 30.9% | 10 | 23.8% | 13 | 30.9% | ||
|
| 7 | 16.6% | 5 | 11.9% | |||||||||||
| CKP (366) | - | 302 | 82.5% | - | 350 | 95.6% | - | 318 | 86.8% | - | 237 | 64.7% | - | 326 | 89.0% |
| ESBL−; Carb− |
| 31 | 8.4% |
| 32 | 8.7% | 33 | 9.0% | 25 | 6.8% | |||||
|
| 13 | 3.5% | 20 | 5.4% | |||||||||||
| ST11-CRKP (3497) | - | 1764 | 50.4% | - | 3496 | 99.9% | - | 3302 | 94.4% | 3400 | 97.2% | - | 2460 | 70.3% | |
| Carb+ |
| 1694 | 48.4% | - | 38 | 1.0% | 936 | 26.7% | |||||||
| ST15-CRKP (311) | - | 174 | 55.9% | - | 311 | 100.0% | - | 310 | 99.6% | 144 | 46.3% | - | 311 | 100.0% | |
| Carb+ |
| 129 | 41.4% | 102 | 32.7% | ||||||||||
| 30 | 9.6% | ||||||||||||||
a Negative of ESBL genes; b negative of carbapenemase; c positive of carbapenemase.
Figure 4Serotype distribution of ST11 carbapenemase-carrying KPN.